• 12/22/2008

    Press release: PAION and ERGOMED complete enrolment of Phase IIa study with CNS 5161 in opioid-refractory cancer pain

  • 12/17/2008

    Press release: PAION's partner Lundbeck initiates clinical phase III trials with Desmoteplase in ischaemic stroke

  • 11/19/2008

    Press release: PAION announces successful completion of Phase I study with the sedative/anaesthetic CNS 7056

  • 11/05/2008

    Press release: PAION AG reports nine-months results 2008

  • 11/03/2008

    Press release: PAION sees improved probability of success for pain drug M6G following successful meta-analysis of clinical data

  • 09/22/2008

    Press release: PAION announces Phase I study with sedative/anaesthetic CNS 7056 progressed to midazolam comparison

  • 08/11/2008

    Press release: PAION AG reports results for the first half-year 2008 and provides strategy update

  • 07/31/2008

    New Supervisory Board Member appointed

  • 07/25/2008

    Press release: PAION announces dosing of first healthy volunteers in Phase I study with its sedative/anaesthetic CNS 7056

  • 07/25/2008

    Regulatory release: Announcement according to Sec 37w WpHG: Publication date for half-year report 2008

  • 07/09/2008

    Press release: PAION announces plan to commence clinical program with its sedative CNS 7056

  • 06/23/2008

    Ad hoc & press release: PAION AG completes acquisition of CeNeS

  • 06/20/2008

    Press release: Court sanctions Scheme of Arrangement for acquisition of CeNeS

  • 05/28/2008

    Press release: shareholders of CeNeS vote for acquisition by PAION

  • 05/21/2008

    PAION's anticoagulant Solulin achieves proof of concept for mode of action in Phase I

  • 05/06/2008

    Press release: PAION Annual General Meeting and CeNeS Acquisition Update

  • 04/29/2008

    Press release: PAION AG reports results for the first quarter 2008

  • 04/23/2008

    Press release: PAION AG acquires world-wide rights to anticoagulant flovagatran from UK company Trigen

  • 04/10/2008

    Ad hoc & press release: PAION AG intends to acquire CeNeS Pharmaceuticals plc

  • 03/03/2008

    Press release: PAION AG reports financial results for fiscal year 2007

  • 02/28/2008

    PAION's anticoagulant Solulin successfully tested in first-in-man study

  • 01/29/2008

    Ad hoc & press release: PAION agreement with Lundbeck comes into force